Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 8/2021

01-08-2021 | Care | Original Paper

Electronic Dissemination of a Web-Based Video Promotes PrEP Contemplation and Conversation Among US Women Engaged in Care at Planned Parenthood

Authors: Sarah K. Calabrese, Susan B. Lane, Abigail Caldwell, Clair Kaplan, John F. Dovidio, Rachel W. Galvao, Damon F. Ogburn, Cara B. Safon, Mehrit Tekeste, Tamara Taggart, Djordje Modrakovic, Brittany C. Wilbourn, Oni Blackstock, Trace S. Kershaw

Published in: AIDS and Behavior | Issue 8/2021

Login to get access

Abstract

We evaluated the acceptability and impact of a web-based PrEP educational video among women (n = 126) by comparing two Planned Parenthood centers: one assigned to a Web Video Condition and one to a Standard Condition. Most women reported the video helped them better understand what PrEP is (92%), how PrEP works (93%), and how to take PrEP (92%). One month post-intervention, more women in the Web Video Condition reported a high level of comfort discussing PrEP with a provider (82% vs. 48%) and commonly thinking about PrEP (36% vs. 4%). No women with linked medical records initiated PrEP during 1-year follow-up.
Appendix
Available only for authorised users
Footnotes
1
In the Standard Condition, the discrepancy between the number of patients who met initial screening criteria and the number meeting inclusion criteria for the analytic sample was due to criteria being slightly broader for screening vs. inclusion in the analytic sample as well as a few patients self-reporting characteristics in the survey that differed from clinician-reported patient characteristics on the screening form (e.g., patient identified as gender queer but clinician recorded the patient’s gender identity as woman or female).
 
Literature
1.
Harris NS, Johnson AS, Huang YA, et al. Vital signs: status of human immunodeficiency virus testing, viral suppression, and HIV preexposure prophylaxis—United States, 2013–2018. Morb Mortal Wkly Rep. 2019;68(48):1117–23. CrossRef
2.
Kwakwa HA, Bessias S, Sturgis D, et al. Engaging United States black communities in HIV pre-exposure prophylaxis: analysis of a PrEP engagement cascade. J Natl Med Assoc. 2018;110(5):480–5.CrossRef
3.
Huang YA, Weiming Z, Smith DK, Harris N, Hoover KW. HIV preexposure prophylaxis, by race and ethnicity—United States, 2014–2016. Morb Mortal Wkly Rep. 2018;67(41):1147–50.CrossRef
4.
Sales JM, Cwiak C, Haddad LB, et al. Brief report: impact of PrEP training for family planning providers on HIV prevention counseling and patient interest in PrEP in Atlanta, Georgia. J Acquir Immune Defic Syndr. 2019;81(4):414–8.CrossRef
5.
Hess KL, Hu X, Lansky A, Mermin J, Hall HI. Lifetime risk of a diagnosis of HIV infection in the United States. Ann Epidemiol. 2017;27(4):238–43.CrossRef
6.
7.
Noar SM, Black HG, Pierce LB. Efficacy of computer technology-based HIV prevention interventions: a meta-analysis. AIDS. 2009;23(1):107–15.CrossRef
8.
Bond KT, Ramos SR. Utilization of an animated electronic health video to increase knowledge of post- and pre-exposure prophylaxis for HIV among African American women: nationwide cross-sectional survey. JMIR Form Res. 2019;3(2):e9995.CrossRef
9.
Chandler R, Hull S, Ross H, Guillaume D, Paul S, Dera N, et al. The pre-exposure prophylaxis (PrEP) consciousness of black college women and the perceived hesitancy of public health institutions to curtail HIV in black women. BMC Public Health. 2020;20(1):1172.CrossRef
10.
Billings DW, Leaf SL, Spencer J, Crenshaw T, Brockington S, Dalal RS. A randomized trial to evaluate the efficacy of a web-based HIV behavioral intervention for high-risk African American women. AIDS Behav. 2015;19(7):1263–74.CrossRef
11.
Card JJ, Kuhn T, Solomon J, Benner TA, Wingood GM, DiClemente RJ. Translating an effective group-based HIV prevention program to a program delivered primarily by a computer: methods and outcomes. AIDS Educ Prev. 2011;23(2):159–74.CrossRef
12.
Jones R, Hoover DR, Lacroix LJ. A randomized controlled trial of soap opera videos streamed to smartphones to reduce risk of sexually transmitted human immunodeficiency virus (HIV) in young urban African American women. Nurs Outlook. 2013;61(4):205-15.e3.CrossRef
13.
Klein CH, Kuhn T, Altamirano M, Lomonaco C. C-SAFE: a computer-delivered sexual health promotion program for Latinas. Health Promot Pract. 2017;18(4):516–25.CrossRef
14.
Wingood GM, Card JJ, Er D, et al. Preliminary efficacy of a computer-based HIV intervention for African-American women. Psychol Health. 2011;26(2):223–34.CrossRef
15.
Amico KR, Balthazar C, Coggia T, Hosek S. Increasing PrEP audio visual representation (PrEP REP) project: development and pilot of a PrEP educational video. International Conference on HIV Treatment and Prevention Adherence. Miami Beach, 2014 [abstract 386].
16.
Field A. Discovering statistics using IBM SPSS statistics. 4th ed. London: SAGE Publications Ltd; 2013.
17.
Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. New York: Routledge; 1988.
18.
Brant AR, Dhillon P, Hull S, Coleman M, Ye PP, Lotke PS, et al. Integrating HIV pre-exposure prophylaxis into family planning care: a RE-AIM framework evaluation. AIDS Patient Care STDS. 2020;34(6):259–66.CrossRef
19.
Auerbach JD, Kinsky S, Brown G, Charles V. Knowledge, attitudes, and likelihood of pre-exposure prophylaxis (PrEP) use among US women at risk of acquiring HIV. AIDS Patient Care STDS. 2015;29(2):102–10.CrossRef
20.
Bond KT, Gunn AJ. Perceived advantages and disadvantages of using pre-exposure prophylaxis (PrEP) among sexually active Black women: an exploratory study. J Black Sex Relatsh. 2016;3(1):1–24.PubMedPubMedCentral
21.
Goparaju L, Praschan NC, Warren-Jeanpiere L, Experton LS, Young MA, Kassaye S. Stigma, partners, providers and costs: potential barriers to PrEP uptake among US Women. J AIDS Clin Res. 2017;8(9):730.CrossRef
22.
Hill LM, Lightfoot AF, Riggins L, Golin CE. Awareness of and attitudes toward pre-exposure prophylaxis among African American women living in low-income neighborhoods in a Southeastern city. AIDS Care. 2021;33(2):239–43.CrossRef
23.
Hirschhorn LR, Brown RN, Friedman EE, Greene GJ, Bender A, Christeller C, et al. Black cisgender women’s PrEP knowledge, attitudes, preferences, and experience in Chicago. J Acquir Immune Defic Syndr. 2020;84(5):497–507.CrossRef
24.
Koren DE, Nichols JS, Simoncini GM. HIV pre-exposure prophylaxis and women: survey of the knowledge, attitudes, and beliefs in an urban obstetrics/gynecology clinic. AIDS Patient Care STDS. 2018;32(12):490–4.CrossRef
25.
Park CJ, Taylor TN, Gutierrez NR, Zingman BS, Blackstock OJ. Pathways to HIV pre-exposure prophylaxis among women prescribed PrEP at an urban sexual health clinic. J Assoc Nurses AIDS Care. 2019;30(3):321–9.CrossRef
26.
Pearson T, Chandler R, McCreary LL, Patil CL, McFarlin BL. Perceptions of African American women and health care professionals related to pre-exposure prophylaxis to prevent HIV. J Obstet Gynecol Neonatal Nurs. 2020;49(6):571–80.CrossRef
27.
Tekeste M, Hull S, Dovidio JF, Safon CB, Blackstock O, Taggart T, et al. Differences in medical mistrust between Black and White women: implications for patient–provider communication about PrEP. AIDS Behav. 2019;23(7):1737–48.CrossRef
28.
Xie L, Wu Y, Meng S, Hou J, Fu R, Zheng H, et al. Risk behavior not associated with self-perception of PrEP candidacy: implications for designing PrEP services. AIDS Behav. 2019;23(10):2784–94.CrossRef
29.
Zhang C, McMahon J, Fiscella K, et al. HIV pre-exposure prophylaxis implementation cascade among health care professionals in the United States: implications from a systematic review and meta-analysis. AIDS Patient Care STDS. 2019;33(12):507–27.CrossRef
30.
Calabrese SK, Krakower DS, Mayer KH. Integrating HIV pre-exposure prophylaxis (PrEP) into routine preventive healthcare to avoid exacerbating disparities. Am J Public Health. 2017;107(12):1883–9.CrossRef
31.
Gamarel KE, Golub SA. Intimacy motivations and pre-exposure prophylaxis (PrEP) adoption intentions among HIV-negative men who have sex with men (MSM) in romantic relationships. Ann Behav Med. 2015;49(2):177–86.CrossRef
Metadata
Title
Electronic Dissemination of a Web-Based Video Promotes PrEP Contemplation and Conversation Among US Women Engaged in Care at Planned Parenthood
Authors
Sarah K. Calabrese
Susan B. Lane
Abigail Caldwell
Clair Kaplan
John F. Dovidio
Rachel W. Galvao
Damon F. Ogburn
Cara B. Safon
Mehrit Tekeste
Tamara Taggart
Djordje Modrakovic
Brittany C. Wilbourn
Oni Blackstock
Trace S. Kershaw
Publication date
01-08-2021
Publisher
Springer US
Published in
AIDS and Behavior / Issue 8/2021
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-021-03210-2

Other articles of this Issue 8/2021

AIDS and Behavior 8/2021 Go to the issue

Original Paper

African American/Black and Latino Adults with Detectable HIV Viral Load Evidence Substantial Risk for Polysubstance Substance Use and Co-occurring Problems: A Latent Class Analysis

Original Paper

Stronger Together: Results from a Randomized Controlled Efficacy Trial of a Dyadic Intervention to Improve Engagement in HIV Care Among Serodiscordant Male Couples in Three US Cities

Original Paper

Slow Uptake of PrEP: Behavioral Predictors and the Influence of Price on PrEP Uptake Among MSM with a High Interest in PrEP

Original Paper

A Pilot Study to Evaluate the Impact of the HIV Infant Tracking System (HITSystem 2.0) on Priority Prevention of Mother-to-Child Transmission (PMTCT) Outcomes

Original Paper

Acceptability of the Dapivirine Vaginal Ring for HIV-1 Prevention and Association with Adherence in a Phase III Trial

Original Paper

Assessing Potential Outcomes Mediation in HIV Interventions
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits